Treatment of hypercholesterolemia in patients with the metabolic syndrome: how do various statins compare?
William Insull Jr
Correspondence Baylor Faculty Center (BCM 620), Suite 08.08, 1709 Dryden Road, Houston, TX 77030-3411, USA
Email winsull@bcm.tmc.edu
This article has no abstract so we have provided the first paragraph of the full text.
This report by Stender et al. provides crucial data supporting the use of statins for treating hypercholesterolemia and reducing the risk of atherosclerotic cardiovascular disease (CVD) in patients with the MS. Ideally, statins should be at least as effective in MS patients as in patients without the MS.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
